Kenneth Myszkowski

Insider Reports History

Location
Pasadena, CA
Signature
/s/Kenneth Myszkowski
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kenneth Myszkowski:

Company Role Class Num Shares Value Price $ Report Date Ownership
ARROWHEAD PHARMACEUTICALS, INC. Chief Financial Officer Common Stock 455,433 $8,967,476 $19.69 07 Jan 2025 Direct

Insider Reports Filed by Kenneth Myszkowski

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ARWR ARROWHEAD PHARMACEUTICALS, INC. 04 Jan 2025 5 -$893,095 4 Chief Financial Officer 07 Jan 2025, 21:27
ARWR ARROWHEAD PHARMACEUTICALS, INC. 06 Mar 2024 1 -$1,407,600 4 Chief Financial Officer 08 Mar 2024, 17:54
ARWR ARROWHEAD PHARMACEUTICALS, INC. 04 Jan 2024 4 -$567,910 4 Chief Financial Officer 08 Jan 2024, 17:16
ARWR ARROWHEAD PHARMACEUTICALS, INC. 27 Jun 2023 1 -$543,000 4 Chief Financial Officer 29 Jun 2023, 18:41
ARWR ARROWHEAD PHARMACEUTICALS, INC. 04 Jan 2023 1 $0 4 Chief Financial Officer 05 Jan 2023, 18:14
ARWR ARROWHEAD PHARMACEUTICALS, INC. 29 Dec 2022 1 -$1,225,000 4 Chief Financial Officer 30 Dec 2022, 16:12
ARWR ARROWHEAD PHARMACEUTICALS, INC. 30 Sep 2022 1 $0 5 Chief Financial Officer 30 Sep 2022, 17:32
ARWR ARROWHEAD PHARMACEUTICALS, INC. 05 Jan 2022 4 -$2,467,941 4 Chief Financial Officer 06 Jan 2022, 19:58
ARWR ARROWHEAD PHARMACEUTICALS, INC. 01 Jan 2022 1 $0 4 Chief Financial Officer 04 Jan 2022, 20:25